HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study
Authors:
- Claudine BekondiCBClaudine Bekondi
- Roberta ZanchiRZRoberta Zanchi
- Abdoulaye SeckASAbdoulaye Seck
- Benoit GarinBGBenoit Garin
- Tamara Giles-VernickTGTamara Giles-Vernick
- Jean Chrysotome GodyJGJean Chrysotome Gody
- Petulla BataPBPetulla Bata
- Angèle PondyAPAngèle Pondy
- Suzie Moyo TetangSTSuzie Moyo Tetang
- Mamadou BaMBMamadou Ba
- Dominique RoussetDRDominique Rousset
Open Access
- 12 July 2015
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 267
Abstract
Hepatitis B is a major health concern in Africa. The vaccine against hepatitis B virus (HBV) was introduced into the Expanded Programme on Immunization (EPI) of Cameroon and Senegal in 2005, and of CAR (Central African Republic) in 2008. A cross-sectional study was conducted to assess HBV immunization coverage following the vaccine’s introduction into the EPI and factors associated with having been vaccinated. All hospitalized children, regardless of the reasons for their hospitalization, between 3 months and 6 years of age, for whom a blood test was scheduled during their stay and whose condition allowed for an additional 2 mL blood sample to be taken, and who provided the parent’s written consent were included. All children anti-HBs- and anti-HBc + were tested for HBsAg. Vaccination coverage was assessed in three different ways: immunization card, maternal recall and serologic anti-HBs profile. 1783 children were enrolled between April 2009 and May 2010. An immunization card was only available for 24 % of the children. The median age was 21 months. Overall HBV immunization coverage based on immunization cards was 99 %, 49 % and 100 % in Cameroon, CAR and Senegal, respectively (p < 0,001). The immunization rate based on maternal recall was 91 %, 17 % and 88 % in Cameroon, CAR and Senegal, respectively (p < 0,001). According to serology (anti-HBs titer ≥ 10 mUI/mL and anti-HBc-), the coverage rate was 68 %, 13 % and 46 % in Cameroon, CAR and Senegal, respectively (p < 0,001). In Senegal and Cameroon, factors associated with having been vaccinated were: mother’s higher education (OR = 2.2; 95 % CI [1.5–3.2]), no malnutrition (OR = 1.6; 95 % CI [1.1–2.2]), access to flushing toilets (OR = 1.6; 95 % CI [1.1–2.3]), and < 24 months old (OR = 2.1; 95 % CI [1.3–3.4] between 12 and 23 months and OR = 2.7; 95 % CI [1.6–4.4] < 12 months). The prevalence of HBV-infected children (HBsAg+) were 0.7 %, 5.1 %, and 0.2 % in Cameroon, CAR and Senegal, respectively (p < 0.001). Assessing immunization coverage based on immunization cards, maternal recall or administrative data could be usefully reinforced by epidemiological data combined with immunological profiles. Serology-based studies should be implemented regularly in African countries, as recommended by the WHO. Malnutrition, lack of maternal education and poverty are factors associated with vaccine non-compliance. The countries’ vaccination programs should actively address these problems.Keywords
This publication has 34 references indexed in Scilit:
- Hepatitis B Virus Exposure During Childhood in Cameroon, Central African Republic and Senegal After the Integration of HBV Vaccine in the Expanded Program on ImmunizationThe Pediatric Infectious Disease Journal, 2013
- Prevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon?BMC Pregnancy and Childbirth, 2013
- Low Immune Response to Hepatitis B Vaccine among Children in Dakar, SenegalPLOS ONE, 2012
- A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in CameroonVirology Journal, 2012
- The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African RepublicBMC Infectious Diseases, 2010
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverageThe Lancet, 2008
- Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypesHepatology Research, 2007
- High prevalence of hepatitis B, C, and E markers in young sexually active adults from The Central African RepublicJournal of Medical Virology, 1995
- Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccineVaccine, 1990